Literature DB >> 11504991

Absence of a recognizable seroconversion illness in Africans infected with HIV-1.

D Morgan1, C Mahe, J Whitworth.   

Abstract

It is difficult to assess the proportion of individuals who experience an acute seroconversion illness after infection with HIV-1. We found that five out of 27 recent HIV-1 seroconverters (18.5%) in a population-based cohort in rural Uganda and four out of 22 HIV-negative controls (18.2%) reported a flu-like illness. More symptoms were reported by seroconverters, but the duration of illness was similar in both groups. We found no association between symptoms and infection with HIV-1 subtype A or D.

Entities:  

Mesh:

Year:  2001        PMID: 11504991     DOI: 10.1097/00002030-200108170-00016

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009.

Authors:  Patrick S Sullivan; Ulgen Fideli; Kristin M Wall; Elwyn Chomba; Cheswa Vwalika; William Kilembe; Amanda Tichacek; Nicole Luisi; Joseph Mulenga; Eric Hunter; Debrah Boeras; Susan Allen
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

2.  Screening for acute HIV infection in South Africa: finding acute and chronic disease.

Authors:  I V Bassett; S Chetty; J Giddy; S Reddy; K Bishop; Z Lu; E Losina; K A Freedberg; R P Walensky
Journal:  HIV Med       Date:  2011-01       Impact factor: 3.180

3.  Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women.

Authors:  Tracy L Lemonovich; Richard R Watkins; Charles S Morrison; Cynthia Kwok; Tsungai Chipato; Robert Musoke; Eric J Arts; Immaculate Nankya; Robert A Salata
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-10-08

4.  Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.

Authors:  Eduard J Sanders; Matthew A Price; Etienne Karita; Anatoli Kamali; William Kilembe; Linda-Gail Bekker; Shabir Lakhi; Mubiana Inambao; Omu Anzala; Patricia E Fast; Jill Gilmour; Kimberly A Powers
Journal:  AIDS       Date:  2017-11-28       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.